Recombinant multi-species STUB1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine STUB1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a protein containing tetratricopeptide repeat and a U-box that functions as a ubiquitin ligase/cochaperone. The encoded protein binds to and ubiquitinates shock cognate 71 kDa protein (Hspa8) and DNA polymerase beta (Polb), among other targets. Mutations in this gene cause spinocerebellar ataxia, autosomal recessive 16. Alternative splicing results in multiple transcript variants. There is a pseudogene for this gene on chromosome 2. [provided by RefSeq, Jun 2014]
The Alternative Names of target: 0610033N24Rik,2210017D18Rik,2310040B03Rik,Antigen NY-CO-7,CHIP,CLL-associated antigen KW-8,Carboxy terminus of Hsp70-interacting protein,Chip,E3 ubiquitin-protein ligase CHIP,HSPABP2,NY-CO-7,RING-type E3 ubiquitin transferase CHIP,SCA48,SCAR16,SDCCAG7,STIP1 homology and U box-containing protein 1,STUB1,Stub1,UBOX1
Go
to STUB1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP3452-Ag-1/ GM-Tg-hg-IP3452-Ag-2 | Human STUB1 protein | Human |
| GM-Tg-rg-IP3452-Ag-1/ GM-Tg-rg-IP3452-Ag-2 | Rat STUB1 protein | Rat |
| GM-Tg-mg-IP3452-Ag-1/ GM-Tg-mg-IP3452-Ag-2 | Mouse STUB1 protein | Mouse |
| GM-Tg-cynog-IP3452-Ag-1/ GM-Tg-cynog-IP3452-Ag-2 | Cynomolgus/Rhesus macaque STUB1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP3452-Ag-1/ GM-Tg-felg-IP3452-Ag-2 | Feline STUB1 protein | Feline |
| GM-Tg-cang-IP3452-Ag-1/ GM-Tg-cang-IP3452-Ag-2 | Canine STUB1 protein | Canine |
| GM-Tg-bovg-IP3452-Ag-1/ GM-Tg-bovg-IP3452-Ag-2 | Bovine STUB1 protein | Bovine |
| GM-Tg-equg-IP3452-Ag-1/ GM-Tg-equg-IP3452-Ag-2 | Equine STUB1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP3452-Ag-1/ GM-Tg-hg-IP3452-Ag-2;
GM-Tg-rg-IP3452-Ag-1/ GM-Tg-rg-IP3452-Ag-2;
GM-Tg-mg-IP3452-Ag-1/ GM-Tg-mg-IP3452-Ag-2; GM-Tg-cynog-IP3452-Ag-1/ GM-Tg-cynog-IP3452-Ag-2; GM-Tg-felg-IP3452-Ag-1/ GM-Tg-felg-IP3452-Ag-2; GM-Tg-cang-IP3452-Ag-1/ GM-Tg-cang-IP3452-Ag-2; GM-Tg-bovg-IP3452-Ag-1/ GM-Tg-bovg-IP3452-Ag-2; GM-Tg-equg-IP3452-Ag-1/ GM-Tg-equg-IP3452-Ag-2 |
| Products Name | STUB1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | STUB1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine STUB1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.